Company: LIMN
Filing Date: 2025-05-06
Form Type: 8-K
Source: 0001104659-25-045127
Chunk: 1

Company: Liminatus Pharma, Inc.
Filing Date: 2025-05-06
Form: 8-K
Item: Item 3.02
Chunk 1
---
Item 3.02. Unregistered Sales of Equity Securities.

The information set forth
in the “ Introductory Note” above is hereby incorporated by reference. The description of the Company’s securities is
contained in the Proxy Statement/Prospectus in the section titled “Iris’s Management’s Discussion and Analysis of
Financial Condition and Results of Operations” beginning on page 177, and “ Certain Relationships and Related Transactions”
beginning on page 222 of the Proxy Statement/Prospectus, which is incorporated herein by reference.